Pacira Pharmaceuticals reported $19.88M in Net Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acelrx Pharmaceuticals ACRX:US $ -8.67M 0.76M
Aerie Pharmaceuticals AERI:US $ -19.37M 16.52M
Amerisourcebergen ABC:US $ 406.96M 141.05M
Astellas Pharma 4503:JP Y 24812M 33220M
Bristol Myers Squibb BMY:US $ 1421M 143M
Cara Therapeutics CARA:US $ -27749000 5.63M
Depomed DEPO:US $ 9.06M 4.46M
Endo International Ordinary Shares ENDP:US $ -71.97M 490.09M
Heron Therapeutics HRTX:US $ -63.89M 9.24M
Horizon Pharma HZNP:US $ 60.97M 143.29M
Ironwood Pharmaceuticals IRWD:US $ 37.08M 1.72M
JAZZ PHA JAZZ:US $ 34.66M 33.02M
Johnson & Johnson JNJ:US $ 4814M 335M
Lannett LCI:US $ -34.9M 46.19M
Ligand Pharmaceuticals LGND:US $ -15.38M 9.97M
Nektar Therapeutics NKTR:US $ -159.07M 68.68M
Pacira Pharmaceuticals PCRX:US $ 19.88M 13.05M
Perrigo Ordinary Shares PRGO:US $ -2.4M 12M
Pfizer PFE:US $ 9905M 2042M
Revance Therapeutics RVNC:US $ -64.34M 1.24M
Supernus Pharmaceuticals SUPN:US $ 7.86M 17.75M
Teva Pharmaceutical TEVA:IT -233000000 722M
Xeris Pharmaceuticals Inc XERS:US -33714000 17.08M
Xoma XOMA:US $ -4670000 2.39M
Zoetis ZTS:US $ 529M 66M